News

Take part in the 5th edition of the Transatlantic Exchanges

Held on March 27, this fifth edition of the Transatlantic Exchanges will focus on “Transatlantic Innovations in Cancer Drug Research

Published on

Save the date Transatlantic Exchanges- Transatlantic Innovations in Cancer Drug Research- Friday, March 27, 2026

Held on March 27, this fifth edition of the Transatlantic Exchanges will focus on “Transatlantic Innovations in Cancer Drug Research”. Registration is now open to attend the event either in person or via videoconference.

Save the date Transatlantic Exchanges- Transatlantic Innovations in Cancer Drug Research- Friday, March 27, 2026

The Transatlantic Exchanges are the result of a partnership between Gustave Roussy and the Dana-Farber Cancer Institute, with the support of the Institut Servier. This annual meeting is dedicated to the latest advances in oncology and has been held alternately in Boston and Paris since 2022.

This 5th edition, entitled “Transatlantic Innovations in Cancer Drug Research” will take place on March 27 in Boston. International experts will focus their presentations on epigenetic therapies, microbiome-driven immunity and cellular pathway reprogramming.

These three areas of research illustrate how emerging technologies and innovative approaches are reshaping oncology worldwide through high-level collaborations.

  • Epigenic therapies do not aim to alter genes themselves, but rather to regulate their activity, preventing cancer cells from exploiting certain mechanisms to grow.
  • Microbiome-driven immunity seeks to understand how the billion of bacteria living in our gut influence the immune system and can enhance the effectiveness of cancer treatments.
  • Cellular pathway reprogramming involves blocking or redirecting the internal circuits of cancer cells that enable them to survive, proliferate, or resist treatment.

Professor Laurence Albiges, Head of the Department of Medical Oncology at Gustave Roussy and an international expert in kidney cancer, will co-chair this fifth edition of the Transatlantic Exchanges alongside Professor Toni Choueiri, Director of the Lank Center for Genitourinary Oncology and Medical Director for International Strategic Initiatives at the Dana-Farber Cancer Institute.

Professor Fabrice Barlesi, CEO of Gustave Roussy, and Dr. Laurie Menger, Group Leader of the “Advanced cell therapies” research team at Gustave Roussy, will also take part as moderators.

Registration open

Registration to attend the event, either in person in Boston or remotely, is open to healthcare professionals interested in oncology: 

► Online registration

Last news

  • Two photon-counting CT scanners now equip Gustave Roussy's imaging department

    Since September 2026, Gustave Roussy's Department of Medical Imaging has been equipped with a second photon-counting CT scanner, delivering higher image resolution while reducing the doses of X-rays and contrast agent administered to patients. This technology recently enabled the Institute to perform an iodine-free pulmonary CT angiogram, a world first.

    Photographie du scanner à comptage photonique
  • Prevention and screening: getting ahead of lung cancer

    To mark Thoracic Cancer Awareness Month and Tobacco-Free Month, two campaigns focusing on lung cancer, Gustave Roussy highlights its initiatives to advance prevention and screening among people at increased risk. Since its creation in 2021, the Institute’s Interception Lung programme has welcomed more than 900 participants, supporting them to stop smoking and offering personalised screening for the disease.

    Photographie : patient effectuant un scanner thoracique et équipes soignantes
  • Gustave Roussy Meets His Audience

    As part of its awareness-raising and fundraising efforts, Gustave Roussy is currently conducting a door-to-door outreach campaign in several towns in Val-de-Marne (Fresnes, Vitry-sur-Seine, Nogent-sur-Marne, Bry-sur-Marne, Le Kremlin-Bicêtre) from Monday through Saturday, 1:30 p.m. to 8:00 p.m.

    Deux personnes en charge de la collecte porte-à-porte
  • Mens November: Take care of your jewelry its precious!

    November is the month dedicated to raising awareness and promoting prevention of male cancers, which include prostate, testicular, and penile cancers. The goal is to raise public awareness of these diseases—which account for approximately 63,000 new cases in France each year—and to encourage men to perform testicular self-exams, a simple step that can help detect a lump, the nature of which must then be determined through further medical examinations. Gustave Roussy has extensive expertise in the treatment of male cancers, particularly through its Genitourinary Oncology Committee, which is deeply involved in research on these diseases. 

    Visuel fixe campagne novembre masculin